Skip to content

We're in Beta! Found a bug? Let us know using the feedback button at the bottom right.

FolioFact
FolioFact
Q3 2026 56/68 funds filed
Latest observation
Sign in Sign up

Some record dates are in the future and are excluded from the latest observation date.

Stock overview

Apogee Therapeutics Inc.

Explore the company, reported ownership, price history, and available source evidence.

Historical Apogee Therapeutics common stock, traded as APGE. AbbVie acquired the company for $135.11 cash per share before trading opened on September 3, 2026. Nasdaq identifies September 2 as the last trading date.

Last close
$135.07
· APGE
Tracked holders
0 funds
Latest available 13F per fund
Latest 13F filed
Date unavailable
Review reported holdings

APGE · USD

Price

$135.07 Change unavailable

Close · Sep 2, 2026

Market closed 1 stored daily close
$135.07 Sep 2, 2026
APGE 5Y closing price chart 1 stored daily close from Sep 2, 2026. Low $135.07; high $135.07.
Sep 2, 2026Sep 2, 2026Sep 2, 2026
Range low
$135.07
Range high
$135.07
Observations
1
Session date
Sep 2, 2026

Sep 2, 2026. Regular market hours only. Historical prices are unadjusted; splits and other corporate actions can affect comparisons.

Investor Popularity

Latest reported institutional positions from SEC 13F filings.

0 holders

No tracked fund's latest available 13F reports APGE.

This state describes the stored filings; it does not imply a current position.

SEC Forms 4/5

Insiders

Reported trades

Financials

Official-source analysis

AI Earnings Report

View all AI Earnings Reports

No published AI Earnings Report yet

We publish a cited AI Earnings Report after an eligible official earnings filing is accepted and passes validation.

Options market

Options

IV30 · daily

Send feedback

Optional — tap one if it fits

We'll only use this to respond to your feedback.